Cargando…
Factors Affecting Human Papillomavirus Vaccine Trends in the United States of America
Background Routine immunization of both girls and boys starting from nine years of age with the human papillomavirus (HPV) vaccine is the current recommendation. The objective of this retrospective study using National Health and Nutrition Examination Survey data was to evaluate the influence of soc...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460605/ https://www.ncbi.nlm.nih.gov/pubmed/37641757 http://dx.doi.org/10.7759/cureus.42617 |
_version_ | 1785097672608186368 |
---|---|
author | Vasireddy, Deepa Sathiyakumar, Thevasha Mondal, Sumona Sur, Shantanu |
author_facet | Vasireddy, Deepa Sathiyakumar, Thevasha Mondal, Sumona Sur, Shantanu |
author_sort | Vasireddy, Deepa |
collection | PubMed |
description | Background Routine immunization of both girls and boys starting from nine years of age with the human papillomavirus (HPV) vaccine is the current recommendation. The objective of this retrospective study using National Health and Nutrition Examination Survey data was to evaluate the influence of sociodemographic factors on the series initiation and completion of the HPV vaccine from 2011 to 2020. Methodology The chi-square test was used to examine the statistical significance of the association between categorical variables and receipt of the HPV vaccine. The Cochran-Armitage test for trend was employed to assess the statistical significance of temporal trends in risk factors associated with rates of HPV vaccination. These trends were further quantified by a significant rate ratio by comparing them against the most recent survey years. Results HPV vaccine uptake was higher in the 9-14-year age group across survey years and had increased for both males and females over that time. The first dose of the HPV vaccine was most likely to be received by the 11-18-year age group. In the most recent survey of 2017-2020, the highest number of vaccination series completion was achieved for Gardasil®. Conclusions Improved physician efforts and strategies to vaccinate males, low socioeconomic strata patients, and ethnic minorities in more numbers are needed. |
format | Online Article Text |
id | pubmed-10460605 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-104606052023-08-28 Factors Affecting Human Papillomavirus Vaccine Trends in the United States of America Vasireddy, Deepa Sathiyakumar, Thevasha Mondal, Sumona Sur, Shantanu Cureus Pediatrics Background Routine immunization of both girls and boys starting from nine years of age with the human papillomavirus (HPV) vaccine is the current recommendation. The objective of this retrospective study using National Health and Nutrition Examination Survey data was to evaluate the influence of sociodemographic factors on the series initiation and completion of the HPV vaccine from 2011 to 2020. Methodology The chi-square test was used to examine the statistical significance of the association between categorical variables and receipt of the HPV vaccine. The Cochran-Armitage test for trend was employed to assess the statistical significance of temporal trends in risk factors associated with rates of HPV vaccination. These trends were further quantified by a significant rate ratio by comparing them against the most recent survey years. Results HPV vaccine uptake was higher in the 9-14-year age group across survey years and had increased for both males and females over that time. The first dose of the HPV vaccine was most likely to be received by the 11-18-year age group. In the most recent survey of 2017-2020, the highest number of vaccination series completion was achieved for Gardasil®. Conclusions Improved physician efforts and strategies to vaccinate males, low socioeconomic strata patients, and ethnic minorities in more numbers are needed. Cureus 2023-07-28 /pmc/articles/PMC10460605/ /pubmed/37641757 http://dx.doi.org/10.7759/cureus.42617 Text en Copyright © 2023, Vasireddy et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Pediatrics Vasireddy, Deepa Sathiyakumar, Thevasha Mondal, Sumona Sur, Shantanu Factors Affecting Human Papillomavirus Vaccine Trends in the United States of America |
title | Factors Affecting Human Papillomavirus Vaccine Trends in the United States of America |
title_full | Factors Affecting Human Papillomavirus Vaccine Trends in the United States of America |
title_fullStr | Factors Affecting Human Papillomavirus Vaccine Trends in the United States of America |
title_full_unstemmed | Factors Affecting Human Papillomavirus Vaccine Trends in the United States of America |
title_short | Factors Affecting Human Papillomavirus Vaccine Trends in the United States of America |
title_sort | factors affecting human papillomavirus vaccine trends in the united states of america |
topic | Pediatrics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460605/ https://www.ncbi.nlm.nih.gov/pubmed/37641757 http://dx.doi.org/10.7759/cureus.42617 |
work_keys_str_mv | AT vasireddydeepa factorsaffectinghumanpapillomavirusvaccinetrendsintheunitedstatesofamerica AT sathiyakumarthevasha factorsaffectinghumanpapillomavirusvaccinetrendsintheunitedstatesofamerica AT mondalsumona factorsaffectinghumanpapillomavirusvaccinetrendsintheunitedstatesofamerica AT surshantanu factorsaffectinghumanpapillomavirusvaccinetrendsintheunitedstatesofamerica |